The company's principal activity is to provide consulting services in connection with product development for various pharmaceutical companies. The company also develops novel application drug delivery systems for marketed prescription and over-the-counter therapeutics. The company's delivery systems are lingual sprays capsules which enables drug absorption through the oral mucosa and more rapid absorption into the bloodstream. The delivery of a therapeutic agent through the oral mucosa leads to a faster onset of action and avoids degradation in the gastrointestinal tract and liver.
